Literature DB >> 34652491

Effect and longevity of botulinum toxin in the treatment of gummy smile: a meta-analysis and meta-regression.

Aline Cristina Soares Zengiski1, Isabela Bittencourt Basso2, Bianca L Cavalcante-Leão3, José Stechman-Neto3, Rosane Sampaio Santos3, Odilon Guariza-Filho4, Bianca Simone Zeigelboim3, Karinna Veríssimo Meira Taveira5, Cristiano Miranda de Araujo6.   

Abstract

OBJECTIVE: The aim of this systematic review is to synthesize the evidence on the effectiveness and longevity of the botulinum toxin in the treatment of individuals with excessive gingival exposure.
METHODS: The search was adapted to six electronic databases and gray literature. The risk of bias was assessed using the Cochrane Risk of Bias Assessment Tool for Non-Randomized and Randomized Studies of Interventions. Meta-analyses and meta-regression were performed using random effects models.
RESULTS: A total of 5247 articles were collected during the final search in the database, resulting in 17 articles included. There was a mean decrease of 3.42 mm [95% CI = -4.50 to -2.34; I2 = 97%] in the level of gingival exposure 2 weeks after the application of botulinum toxin. The application time explained 29.58% of the observed variance (p < 0.001), with a tendency for the effect size to decrease from the second week of application onwards, with values returning close to baseline levels in 24 weeks.
CONCLUSION: Botulinum toxin is an alternative technique considered effective for reducing gummy smile, especially for gummy smiles up to 4 mm, with a longevity of at least 12 weeks, returning close to initial values within 24 weeks after application. CLINICAL RELEVANCE: The knowledge about the longevity and effectiveness of botulinum toxin in the treatment of gummy smile allows for a more adequate clinical planning for these cases, as well as for clinical decisions, as for prognostic factors.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Botulinum toxins, Type A; Gummy smile; Longevity; Meta-analysis

Mesh:

Substances:

Year:  2021        PMID: 34652491     DOI: 10.1007/s00784-021-04223-w

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  21 in total

1.  Botulinum Toxin Type-A for the Treatment of Excessive Gingival Display on Smiling.

Authors:  Jibin Skaria; Nanditha Hegde; Pradeep P George; Tony Michael; Joseph Sebastian
Journal:  J Contemp Dent Pract       Date:  2020-09-01

2.  Botulinum Toxin for the Treatment of Gummv Smile.

Authors:  Afnan F Al-Fouzan; Lamia S Mokeem; Reem T Al-Saqat; Maisa A Alfalah; Mana A Alharbi; Abdullah E Al-Samary
Journal:  J Contemp Dent Pract       Date:  2017-06-01

Review 3.  Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis.

Authors:  Taísa Figueiredo Chagas; Natalia Valli de Almeida; Cinthia Oliveira Lisboa; Daniele Masterson Tavares Pereira Ferreira; Claudia Trindade Mattos; José Nelson Mucha
Journal:  Braz Oral Res       Date:  2018-05-07

4.  Botulinum toxin type A in the treatment of excessive gingival display.

Authors:  Mario Polo
Journal:  Am J Orthod Dentofacial Orthop       Date:  2005-02       Impact factor: 2.650

5.  Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile).

Authors:  Mario Polo
Journal:  Am J Orthod Dentofacial Orthop       Date:  2008-02       Impact factor: 2.650

6.  To evaluate the effect and longevity of Botulinum toxin type A (Botox®) in the management of gummy smile - A longitudinal study upto 4 years follow-up.

Authors:  Athreya Rajagopal; Manoj Goyal; Sagrika Shukla; Neeti Mittal
Journal:  J Oral Biol Craniofac Res       Date:  2021-02-10

7.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

8.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

9.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29

10.  Efficacy of botulinum toxin for treating a gummy smile.

Authors:  Ahmet Fatih Cengiz; Merve Goymen; Cenk Akcali
Journal:  Am J Orthod Dentofacial Orthop       Date:  2020-05-12       Impact factor: 2.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.